We are live on ! Find out more
OCM

Ovata Capital Management Portfolio holdings

AUM $1.33B
1-Year Est. Return 5.69%
This Fund
S&P 500
This Quarter Est. Return
+12.09%
1 Year Est. Return
+5.69%
3 Year Est. Return
+69.09%
5 Year Est. Return
+58.06%
10 Year Est. Return
–
AUM
$135M
AUM Growth
–
Cap. Flow
+$128M
Cap. Flow %
94.82%
Top 10 Hldgs %
75.69%
Holding
32
New
31
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
TAK icon
Takeda Pharmaceutical
TAK
+$16.8M
2
QFIN icon
Qfin Holdings
QFIN
+$9.05M
3
NFH
New Frontier Health Corporation Ordinary Shares
NFH
+$8.17M
4
SONY icon
Sony
SONY
+$6.57M
5
NXPI icon
NXP Semiconductors
NXPI
+$6.04M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Technology 18.09%
2 Financials 16.74%
3 Healthcare 13.04%
4 Consumer Discretionary 10.16%
5 Consumer Staples 7.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
LX
26
PUT
LexinFintech Holdings
LX
$244M
– –
0
– –
1
2

Similar funds

RCM
Radcliffe Capital Management Bala Cynwyd, Pennsylvania $1.33B AUM 1.18% 1-Year Est. Return
AWA
Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return
WA
WBH Advisory Baltimore, Maryland $1.34B AUM 15.16% 1-Year Est. Return
CRAM
Compass Rose Asset Management New York $1.33B AUM 2.38% 1-Year Est. Return
4WM
49 Wealth Management Austin, Texas $1.34B AUM 12.81% 1-Year Est. Return
BFMH
Baring Fintech Manager Holding Castel, Guernsey $1.34B AUM 20.23% 1-Year Est. Return
NEWAS
N.E.W. Advisory Services De Pere, Wisconsin $1.34B AUM 15.38% 1-Year Est. Return
SWM
SHP Wealth Management Plymouth, Massachusetts $1.33B AUM

Ovata Capital Management's Q4 2019 Portfolio in Review

Q4 2019 is the first quarter with a 13F filing on record for Ovata Capital Management, which disclosed 32 positions worth $135M. Its ten largest holdings account for 76% of the portfolio.

Its largest position is Takeda Pharmaceutical: 879,800 shares worth $17.6M.

By sector, the portfolio is most concentrated in Technology at 18% of assets, followed by Financials and Healthcare.

  • Ovata Capital Management's largest Q4 2019 buy was Takeda Pharmaceutical: 879,800 shares worth $17.6M.
  • Ovata Capital Management's ten largest holdings make up 76% of its $135M portfolio in Q4 2019.
  • Ovata Capital Management disclosed 32 positions in Q4 2019, its first 13F filing on record.

Based on Ovata Capital Management's 13F filing for Q4 2019, filed 14 Feb 2020.